Corvus Pharmaceuticals shares surge ahead of Phase 1 data release for Soquelitinib
Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company, is poised to announce interim results from its Phase 1 trial evaluating soquelitinib as a potential treatment for moderate ... Read More